ACCURAY INC (ARAY)
US0043971052 - Common Stock
Taking everything into account, ARAY scores 3 out of 10 in our fundamental rating. ARAY was compared to 195 industry peers in the Health Care Equipment & Supplies industry. ARAY has a bad profitability rating. Also its financial health evaluation is rather negative. ARAY has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ARAY had negative earnings in the past year.
In the past year ARAY had a positive cash flow from operations.
ARAY had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARAY reported negative operating cash flow in multiple years.
1.2 Ratios
With a decent Return On Assets value of -3.07%, ARAY is doing good in the industry, outperforming 66.15% of the companies in the same industry.
ARAY's Return On Equity of -30.68% is in line compared to the rest of the industry. ARAY outperforms 57.44% of its industry peers.
ARAY has a Return On Invested Capital of 0.78%. This is in the better half of the industry: ARAY outperforms 69.74% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ARAY is significantly below the industry average of 8.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -30.68% | ||
| ROIC | 0.78% |
ROA(3y)-1.46%
ROA(5y)-1.47%
ROE(3y)-12.15%
ROE(5y)-12.67%
ROIC(3y)3.07%
ROIC(5y)2.52%
1.3 Margins
ARAY has a Operating Margin of 0.59%. This is in the better half of the industry: ARAY outperforms 68.72% of its industry peers.
ARAY's Operating Margin has declined in the last couple of years.
ARAY has a Gross Margin of 33.96%. This is in the lower half of the industry: ARAY underperforms 69.23% of its industry peers.
ARAY's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.59% | ||
| PM (TTM) | N/A | ||
| GM | 33.96% |
OM growth 3Y-45.24%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-2.94%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARAY is destroying value.
The number of shares outstanding for ARAY has been increased compared to 1 year ago.
ARAY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ARAY has been reduced compared to a year ago.
2.2 Solvency
ARAY has an Altman-Z score of 0.05. This is a bad value and indicates that ARAY is not financially healthy and even has some risk of bankruptcy.
ARAY has a Altman-Z score (0.05) which is comparable to the rest of the industry.
ARAY has a debt to FCF ratio of 22.95. This is a negative value and a sign of low solvency as ARAY would need 22.95 years to pay back of all of its debts.
ARAY's Debt to FCF ratio of 22.95 is fine compared to the rest of the industry. ARAY outperforms 70.77% of its industry peers.
A Debt/Equity ratio of 3.53 is on the high side and indicates that ARAY has dependencies on debt financing.
With a Debt to Equity ratio value of 3.53, ARAY is not doing good in the industry: 88.21% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.53 | ||
| Debt/FCF | 22.95 | ||
| Altman-Z | 0.05 |
ROIC/WACC0.08
WACC9.39%
2.3 Liquidity
ARAY has a Current Ratio of 1.58. This is a normal value and indicates that ARAY is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.58, ARAY is not doing good in the industry: 81.03% of the companies in the same industry are doing better.
ARAY has a Quick Ratio of 1.58. This is a bad value and indicates that ARAY is not financially healthy enough and could expect problems in meeting its short term obligations.
ARAY has a worse Quick ratio (0.84) than 87.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
ARAY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.38%.
Looking at the last year, ARAY shows a small growth in Revenue. The Revenue has grown by 7.19% in the last year.
Measured over the past years, ARAY shows a small growth in Revenue. The Revenue has been growing by 2.03% on average per year.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-400%
Revenue 1Y (TTM)7.19%
Revenue growth 3Y5.34%
Revenue growth 5Y2.03%
Revenue growth Q2Q-6.59%
3.2 Future
The Earnings Per Share is expected to grow by 57.92% on average over the next years. This is a very strong growth
Based on estimates for the next years, ARAY will show a small growth in Revenue. The Revenue will grow by 4.52% on average per year.
EPS Next Y15.85%
EPS Next 2Y83.3%
EPS Next 3Y57.92%
EPS Next 5YN/A
Revenue Next Year2.45%
Revenue Next 2Y4.18%
Revenue Next 3Y4.52%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ARAY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 16.32, the valuation of ARAY can be described as correct.
Based on the Price/Forward Earnings ratio, ARAY is valued cheaper than 90.77% of the companies in the same industry.
ARAY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.60.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 16.32 |
4.2 Price Multiples
70.77% of the companies in the same industry are more expensive than ARAY, based on the Enterprise Value to EBITDA ratio.
86.15% of the companies in the same industry are more expensive than ARAY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.91 | ||
| EV/EBITDA | 41.56 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ARAY's earnings are expected to grow with 57.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y83.3%
EPS Next 3Y57.92%
5. Dividend
5.1 Amount
No dividends for ARAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ACCURAY INC
NASDAQ:ARAY (4/23/2024, 7:00:00 PM)
After market: 2.22 0 (0%)2.22
+0.05 (+2.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap220.16M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 16.32 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -30.68% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 0.59% | ||
| PM (TTM) | N/A | ||
| GM | 33.96% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.53 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.58 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y15.85%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.19%
Revenue growth 3Y5.34%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y